Bolt BiotherapeuticsBOLT
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 38 institutions reported holding Bolt Biotherapeutics Inc. (BOLT) in their 13F filings, up 6 from Q3 2024. 9 opened new positions and 5 sold out. The largest holders were Tang Capital Management LLC ($2.0M), Vivo Capital, LLC ($1.9M) and Sofinnova Investments, Inc. ($1.5M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Bolt Biotherapeutics Inc.
- CUSIP
- 097702104
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $226K |
| Exits | 5 | $779K |
All 13F filers, Q3 2024 → Q4 2024: 492,581 shares bought and 1,246,043 shares sold, net −753,462 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 38 holders
| Tang Capital Management LLC | 0.14% | No change | 3,812,773 | $2.0M |
| Vivo Capital, LLC | 0.21% | No change | 3,521,291 | $1.9M |
| Sofinnova Investments, Inc. | 0.11% | No change | 2,754,437 | $1.5M |
| Pivotal bioVenture Partners Investment Advisor LLC | 0.69% | No change | 1,891,467 | $1.0M |
| Nan Fung Group Holdings Ltd | 0.53% | No change | 1,166,952 | $624K |
| Vanguard Group Inc. | 0.00% | No change | 1,067,405 | $571K |
| Samsara Biocapital, LLC | 0.08% | No change | 1,049,153 | $561K |
| Board of Trustees of The Leland Stanford Junior University | 0.03% | No change | 719,546 | $385K |
| Pfizer Inc | 0.01% | — | 626,109 | $335K |
| Geode Capital Management, LLC | 0.00% | Reduce -3.3% | 340,674 | $182K |
| Renaissance Technologies | 0.00% | Add +2.7% | 302,039 | $162K |
| BlackRock, Inc. | 0.00% | Add +0.2% | 270,092 | $145K |
| ADAR1 Capital Management, LLC | 0.03% | No change | 244,966 | $131K |
| FMR LLC | 0.00% | Add +12.0% | 129,254 | $69K |
| Citadel Advisors | 0.00% | New | 78,961 | $42K |
| Engineers Gate Manager LP | 0.00% | New | 72,402 | $39K |
| UBS Group AG | 0.00% | Add +87.3% | 66,113 | $35K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 60,200 | $32K |
| Goldman Sachs Group Inc. | 0.00% | New | 50,020 | $27K |
| Velan Capital Investment Management LP | 0.02% | New | 50,000 | $27K |
| Squarepoint Ops LLC | 0.00% | New | 48,971 | $26K |
| State Street Corp. | 0.00% | No change | 47,437 | $25K |
| Millennium Management | 0.00% | New | 47,025 | $25K |
| XTX Topco Ltd | 0.00% | New | 44,891 | $24K |
| Jane Street Group, LLC | 0.00% | Add +49.0% | 41,868 | $22K |
| Northern Trust Corp. | 0.00% | No change | 40,895 | $22K |
| Mariner, LLC | 0.00% | Reduce -13.7% | 35,000 | $19K |
| Virtu Financial LLC | 0.00% | New | 29,552 | $16K |
| Assenagon Asset Management S.A. | 0.00% | No change | 20,785 | $11K |
| Morgan Stanley | 0.00% | Reduce -50.5% | 11,616 | $6K |
| Bank of America Corp. | 0.00% | Reduce -6.3% | 5,625 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +2078.3% | 4,008 | $2K |
| Osaic Holdings, Inc. | 0.00% | Reduce -86.4% | 2,355 | $1K |
| JPMorgan Chase & Co. | 0.00% | Reduce -0.3% | 911 | $487 |
| SBI Securities Co., Ltd. | 0.00% | — | 200 | $107 |
| Barclays PLC | 0.00% | No change | 139 | $74 |
| Salem Investment Counselors Inc. | 0.00% | No change | 40 | $22 |
| BNP Paribas Financial Markets | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is BOLT's weight in each manager's 13F, not the share of Bolt Biotherapeutics Inc. the manager owns.